249 related articles for article (PubMed ID: 22492208)
1. Immunohistochemical characterization of feline mast cell tumors.
Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
[TBL] [Abstract][Full Text] [Related]
2. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
3. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
6. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia.
Litster AL; Sorenmo KU
J Feline Med Surg; 2006 Jun; 8(3):177-83. PubMed ID: 16476559
[TBL] [Abstract][Full Text] [Related]
9. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
Preziosi R; Morini M; Sarli G
J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
[TBL] [Abstract][Full Text] [Related]
10. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
[TBL] [Abstract][Full Text] [Related]
11. Mast cell tumors in cats: clinical update and possible new treatment avenues.
Henry C; Herrera C
J Feline Med Surg; 2013 Jan; 15(1):41-7. PubMed ID: 23254240
[TBL] [Abstract][Full Text] [Related]
12. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
[TBL] [Abstract][Full Text] [Related]
13. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
15. Mast cell tumors of the gastrointestinal tract in 39 dogs.
Ozaki K; Yamagami T; Nomura K; Narama I
Vet Pathol; 2002 Sep; 39(5):557-64. PubMed ID: 12243465
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985).
Buerger RG; Scott DW
J Am Vet Med Assoc; 1987 Jun; 190(11):1440-4. PubMed ID: 3112049
[TBL] [Abstract][Full Text] [Related]
17. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
Meyer A; Gruber AD; Klopfleisch R
Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
[TBL] [Abstract][Full Text] [Related]
18. Canine mast cell tumors express stem cell factor receptor.
Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
[TBL] [Abstract][Full Text] [Related]
20. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours.
Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G
Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
